| Active-Ingredient | Lapatinib |
|---|---|
| Indication | Breast cancer |
| Manufacturers | GlaxoSmithKline Pharmaceuticals Ltd |
| Packaging | 30 tablets in 1 bottle |
| Strength | 250mg |
| Drug Class | Tyrosine Kinase Inhibitor (TKI)/Antineoplastic agent/ HER2 inhibitor/EGFR inhibitor |
| Dosage Form | Oral Film-Coated Tablet |
| Delivery-Time | 6 To 15 days |
No key features available.

